Home › Funds › BML Capital Management, LLC › ENGN
BML Capital Management, LLC position in ENGN
ENGENE THERAPEUTICS INC · Health Care
BML Capital Management, LLC reported holding 6,669,908 shares of ENGN (ENGENE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$13.3M, representing 7.11% of its reported portfolio and ranking #3 among its reported holdings. BML Capital Management, LLC has disclosed ENGN holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How BML Capital Management, LLC's ENGN position evolved
BML Capital Management, LLC first disclosed a stake in ENGN in Q2 2026 at 6,669,908 shares (US$11.5M). The position peaked in Q3 2026 at 6,669,908 shares, worth US$13.3M. Across 2 filings, BML Capital Management, LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 6,669,908 shares valued at US$13.3M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 6.67M | $11.54M | New |
| Q3 2026 | 6.67M | $13.34M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ENGN and 13F data
ENGN (ENGENE THERAPEUTICS INC) is a Health Care company. 27 other funds we track also report a position in ENGN — the largest reported positions include FCPM III SERVICES B.V. (US$16.7M), Nextech Invest Ltd. (US$4.0M), ACORN CAPITAL ADVISORS, LLC (US$2.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ENGN
- FCPM III SERVICES B.V. 9.63M sh · $16.66M · Q2 2026
- Nextech Invest Ltd. 2.32M sh · $4.02M · Q2 2026
- ACORN CAPITAL ADVISORS, LLC 1.27M sh · $2.20M · Q2 2026
- Peapod Lane Capital LLC 1.04M sh · $2.08M · Q3 2026
- Omega Fund Management, LLC 876.36K sh · $1.52M · Q2 2026
- Aldebaran Capital, LLC 657.32K sh · $1.31M · Q3 2026
- SR ONE CAPITAL MANAGEMENT, LP 747.75K sh · $1.29M · Q2 2026
- Kynam Capital Management, LP 457.86K sh · $792.09K · Q2 2026
- Elmind Capital, LP 210.00K sh · $363.30K · Q2 2026
More on BML Capital Management, LLC
FAQ
How long has BML Capital Management, LLC held ENGN?
BML Capital Management, LLC has disclosed ENGN holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is BML Capital Management, LLC's current position in ENGN?
As of Q3 2026, BML Capital Management, LLC holds 6.67M shares of ENGN (ENGENE THERAPEUTICS INC), valued at $13.34M, representing 7.11% of its reported portfolio and ranking #3.
Has BML Capital Management, LLC been buying or selling ENGN?
In the latest 13F filing (Q3 2026), BML Capital Management, LLC held unchanged its position in ENGN. The position peaked in Q3 2026 at 6.67M shares.
Which other funds hold ENGN?
Other major institutional holders of ENGN include FCPM III SERVICES B.V., Nextech Invest Ltd., ACORN CAPITAL ADVISORS, LLC, among 27 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.